Speech-Language Pathologists in Renton, WA Accepting Medicare

89 Speech-Language Pathologists found. Showing 41 - 60

Anita Desiree Johnson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-656-5516    Fax: 425-656-4028

Alexandra Mary Ancharski, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1119 Sw 7th St, Renton, WA 98057 Phone: 206-691-2598

Jennifer Ponsford, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3600 Lind Ave Sw, Ste 160, Renton, WA 98055 Phone: 425-656-4215    Fax: 425-656-5075

Amy Susan Faherty, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-656-5516    Fax: 425-656-4028

Henry Loh Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Sw 7th St, Renton, WA 98057 Phone: 425-204-2285

Ms. Barbara Perry, MASP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Sw 7th St, Renton, WA 98057 Phone: 425-204-4228

Khue Thi Tran, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-251-5175    Fax: 425-656-4028

Emily Nicole Villa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-251-5165    Fax: 425-251-5165

Ms. Larisa Roxanne Sanchez, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 South Grady Way #336, Renton, WA 98057 Phone: 425-988-3744    Fax: 425-687-2646

Heather Sather Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 Union Ave Ne, Renton, WA 98059 Phone: 425-204-4813

Nichole Michelle Lessard, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3600 Lind Ave Sw, Suite 160, Renton, WA 98057 Phone: 425-656-4215

Julie Stratton, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 425 Sw 41st St, Renton, WA 98055 Phone: 425-291-9200

Sydney Marie Zenzen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17420 106th Pl Se, Renton, WA 98055 Phone: 425-362-6200

Daniella Riani Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-251-5165    Fax: 425-656-4028

Liana S Malamed, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Sw 7th St, Renton, WA 98057 Phone: 425-204-2302

Daphne Brindle, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12918 172nd Ave Se, Renton, WA 98059 Phone: 206-953-1398

Schotzi Eggleston, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1211 Dayton Ave Ne, Renton, WA 98056 Phone: 206-999-8280

Nara R Conner, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4430 Talbot Rd S, Renton, WA 98055 Phone: 425-226-7500

Miss Stephanie Pew, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18235 140th Ave Se, Renton, WA 98058 Phone: 253-373-2012

Jenny Lynn Alden, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 S 43rd St, Renton, WA 98055 Phone: 425-251-5165    Fax: 425-656-4028

News Archive

PFC exposure can lead to early menopause in women

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that higher levels of perfluorocarbons in the body are associated with increased odds of having experienced menopause in women between 42 and 64 years old. Women in this age group with high levels of PFCs also had significantly lower concentrations of estrogen when compared to women who had low levels of PFCs.

Medivir, Bristol-Myers Squibb to initiate TMC435 and daclatasvir phase II combination study in HCV

Medivir AB, the research-based pharmaceutical company focused on the development of high-value treatments for infectious diseases, announces that a phase II combination study with the investigational compound TMC435 and Bristol-Myers Squibb's investigational compound daclatasvir will start in July.

New nanoparticle approach can deliver antiobesity drugs directly to fat tissue

Researchers at MIT and Brigham and Women's Hospital have developed nanoparticles that can deliver antiobesity drugs directly to fat tissue. Overweight mice treated with these nanoparticles lost 10 percent of their body weight over 25 days, without showing any negative side effects.

Does abdominal fat affect COVID-19 outcomes?

As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.

Read more Medical News

› Verified 6 days ago

• 1
• 2
• 3(current)
• 4
• 5